The table below shows Atara Biotherapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$120.77M
$128.94M
$8.57M
$63.57M
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$37.45M
$151.48M
$224.78M
$272.53M
$282.00M
$244.65M
SG&A
$26.25M
ATRA annual revenue (10-K history)
Atara Biotherapeutics, Inc. reported annual revenue of $120.77M for fiscal year 2025. That is down 6.3% from $128.94M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.